Legal 500
Log in or register
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR

© 2026 Legalease Ltd. All rights reserved

Registered company in England & Wales No. 02427356 VAT GB 321 5727 22

Registered address: 188 Fleet Street, London, EC4A 2AG

  • Legal 500 Trust Centre
  • Contact Us
  • home
  • Market Intelligence
  • Search

371 results found

Use advanced search filters to refine your search

2 filters applied

Advanced search filters

Topics
Countries
Contributor

Start typing to add contributors

Content type
Show options
  • Article

    Recent Developments in Pharmaceutical and Bioethics Law

    >Law n° 2004-806 dated 9 August 2004 relating to health care policy implements the EU Clinical Trials Directive 2001/20/EC of 4 April 2001 on medicinal products for humans and reforms the French law n° 88-1138 "Huriet-Sérusclat" of 20 December 1988 on the protection of clinical trial subjects.
    FranceInsurance
    Lovells
    Lovells
  • Article

    Foreign Investment And Trade Opportunities - An Overview

    FranceFamily and Matrimonial
    Pricewaterhouse Coopers
    Pricewaterhouse Coopers
  • Article

    French Tax Aspects Of Exchange Rate And Interest Rate Risk Management - Current

FranceAntitrust/Competition Law
SG Archibald Andersen
SG Archibald Andersen
  • Article

    Procedures For Tender Offers - Normal Procedure

    FranceAntitrust/Competition Law
    Shearman & Sterling
    Shearman & Sterling
  • Article

    1997 Finance Act/Amended 1996 Finance Act

    FranceAccounting and Audit
    SG Archibald Andersen
    SG Archibald Andersen
  • Article

    Listing And Issuance Of Securities In France

    FranceAntitrust/Competition Law
    Shearman & Sterling
    Shearman & Sterling
  • Article

    Permitted Trading Hours In France And Other Countries In Europe

    FranceFinance and Banking
    Clifford Chance
    Clifford Chance
  • Article

    Foreign Investors on Financial Markets

    FranceAntitrust/Competition Law
    SG Archibald Andersen
    SG Archibald Andersen
  • Article

    Tax Regime of Derivative Products on Shares

    FranceAccounting and Audit
    SG Archibald Andersen
    SG Archibald Andersen
  • Article

    Information To Be Furnished By A Non-French Company Listed In France

    FranceAntitrust/Competition Law
    Shearman & Sterling
    Shearman & Sterling
  • Article

    French Rules Applicable To Securitisation - Part II

    FranceEmployment and HR
    SG Archibald Andersen
    SG Archibald Andersen
  • Article

    Banking, Finance & Insurance Letter - Juin-Juillet 2016

    L'ESMA a publié le 19 juillet 2016 une mise à jour de ses questions-réponses relatives à l'application de la Directive du 23 juillet 2014 n° 2014/91/UE (dite « OPCVM V »).
    FranceFinance and Banking
    Herbert Smith Freehills Kramer LLP
    Herbert Smith Freehills Kramer LLP
  • Article

    Investment Incentives - An Overview

    FranceStrategy
    Pricewaterhouse Coopers
    Pricewaterhouse Coopers
  • Article

    COVID-19: Legal Issues, Considerations And Tips As Of July1, 2020

    The COVID-19 pandemic affect billions of people worldwide and has an increasingly devastating impact on the economy.
    FranceCoronavirus (COVID-19)
    Soulier Avocats
    Soulier Avocats
  • Article

    Regulatory Ratios Applicable To The French Banking Sector

    FranceLitigation, Mediation & Arbitration
    Arthur Andersen
    Arthur Andersen
  • Article

    L'assurance De La Garantie De Passif En Synthèse

    L'assurance permet d'éviter une exposition du cédant sur le long terme.
    FranceInsurance
    Courtois Lebel
    Courtois Lebel
  • Article

    Insurance Alert - Et DDA Fut Transposée

    C'est peu dire que le texte de transposition de la directive DDA était attendu, au point que l'on est en droit de se demander s'il n'est pas quelque peu tardif au regard ...
    FranceInsurance
    Herbert Smith Freehills Kramer LLP
    Herbert Smith Freehills Kramer LLP
  • Article

    Acquiring An Unlisted Company In France - Ten Golden Rules

    FranceCorporate/Commercial Law
    Clifford Chance
    Clifford Chance
  • Article

    Restrictions On Foreign Investment And Investors

    FranceGovernment, Public Sector
    Pricewaterhouse Coopers
    Pricewaterhouse Coopers
  • Article

    Investment Incomes

    FranceAccounting and Audit
    SG Archibald Andersen
    SG Archibald Andersen
  • Showing 341–360 of 371 results

    PreviousNext
    Legal Intelligence Newsletters: sign up for the latest legal and regulatory news on your chosen topics